Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alltrna
Biotech
Arch-backed tRNA biotech shutters after viewing preclinical data
HC Bioscience is shutting down after conducting preclinical models for a tRNA asset designed to treat hemophilia A.
Gabrielle Masson
Mar 18, 2025 10:15am
Amylyx preps for GLP-1 launch with new CCO—Chutes & Ladders
Jan 10, 2025 8:30am
3 Flagship biotechs make key exec hires—Chutes & Ladders
Aug 18, 2023 9:30am
Flagship's Alltrna collects $109M to Stop Codon Disease
Aug 9, 2023 6:00am
Ayala, Advaxis merger means new leadership team—Chutes & Ladders
Oct 21, 2022 9:30am
Takeda, Arch fund hC Bio with $24M for transfer RNAs
Feb 24, 2022 11:00am
